title: An omental mass: any hypothesis?
authors.forename: M
authors.initials: M
authors.lastname: Caricato
authors.forename: F
authors.initials: F
authors.lastname: Ausania
authors.forename: S
authors.initials: S
authors.lastname: Valeri
authors.forename: C
authors.initials: C
authors.lastname: Rabitti
authors.forename: G
authors.initials: G
authors.lastname: Tonini
authors.forename: R
authors.initials: R
authors.lastname: Coppola
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D013505:Digestive System Surgical Procedures; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000556:secondary* / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D009852:Omentum; D010534:Peritoneal Neoplasms / Q000473:pathology* / Q000601:surgery; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013160:Splenic Neoplasms / Q000188:drug therapy / Q000556:secondary*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate